Results 211 to 220 of about 93,748 (310)
Purtscher-like retinopathy and paracentral acute middle maculopathy associated with improper antihypertensive drug use: a case report. [PDF]
Meng Y +7 more
europepmc +1 more source
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi +10 more
wiley +1 more source
Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study. [PDF]
Zheng H, Wu S, Wang W, Qiu W, Feng Y.
europepmc +1 more source
Abstract Aims The impact of steatotic liver disease (SLD) subtypes on incident type 2 diabetes remains unclear. We investigated the association of metabolic dysfunction‐associated steatotic liver disease (MASLD), MetALD (MASLD with moderate alcohol consumption), and alcohol‐related liver disease (ALD) with incident type 2 diabetes in Korean adults aged
Goh Eun Chung +6 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Moritz M. Hollstein +4 more
wiley +1 more source
Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani +5 more
wiley +1 more source
Genetically determined blood pressure, antihypertensive drug classes, and frailty: A Mendelian randomization study. [PDF]
Zhuang Z +13 more
europepmc +1 more source

